AI Article Synopsis
- The compound eye research focuses on miniaturizing imaging systems, introducing a dual compound eye with three micro lens arrays featuring aspheric surfaces.
- This system operates in two states: as a superposition system capturing the entire field of view and as an apposition system that images only sections for a larger overall field of view.
- Additionally, implementing a field stop reduces stray light and optimizes the modulation transfer function (MTF) of the ideal superposition compound eye.
Article Abstract
Compound eye is a new field of research about miniaturizing imaging systems. We for the first time introduce a dual compound eye that contains three micro lens arrays with aspheric surfaces. The designed dual compound eye in one state is a superposition system in which each channel images all of field of view of the system. With adding a field stop we have decreased the stray light. MTF of ideal superposition compound eye calculated. Also with changing field stop the system is converted to an apposition compound eye in which each channel images only a part of total field of view and so the field of view is larger than that of superposition type.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1364/OE.18.012304 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Undaria pinnatifida fucoidan extract inhibits activation of the NF-κB signaling pathway by herpes simplex virus type 1 and prevents amyloid-β peptide synthesis in retinal pigment epithelium cells.
Arch Virol
January 2025
Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur-Bahía Blanca, Buenos Aires, Argentina.
Neurodegenerative pathologies such as age-related macular degeneration currently have no cure or effective treatment. In this type of disease, the presence of amyloid-β peptides, oxidative stress, and inflammation trigger dysregulation of retinal pigment epithelial cells and progression toward the death of these cells, resulting in a loss of vision. The production of amyloid-β peptides, oxidative stress, and inflammation can be triggered in response to viral infections.
View Article and Find Full Text PDFDeciphering the Genetic and Epidemiological Landscape of Inherited Retinal Diseases (IRDs) in a Cohort of Eastern Iranian Patients.
Clin Genet
January 2025
Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Inherited retinal diseases (IRDs) may have significant diagnostic challenges due to their genetic complexity and diverse inheritance patterns. Advanced genotyping tools like exome sequencing (ES) offer promising opportunities for identifying causative variants and improving disease management. This retrospective study was aimed to present prevalent pathogenic and novel variants in patients diagnosed with IRDs using ES.
View Article and Find Full Text PDFCovalent Inhibitor Screening for Targeting LOXL2: Studied by Virtual Screening and Experimental Validation.
Recent Pat Anticancer Drug Discov
January 2025
Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou, 515041, PR China.
Background: Lysyl oxidase-like 2 (LOXL2) is a metalloenzyme that catalyzes oxidative deamination ε-amino group of lysine. It has been found that LOXL2 is a promotor for the metastasis and invasion in kinds of tumors. Previous studies show that disulfide bonds are important components in LOXL2, and their bioactivity can be regulated by those bonds.
View Article and Find Full Text PDFDevelopment of Research Foundation for Comprehensive Articulation of Drug Effects.
Biol Pharm Bull
January 2025
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
As unexpected adverse events and successful drug repositioning have shown, drug effects are complex and include aspects not recognized by developers. How can we understand these unrecognized drug effects? Drug effects can be numerized by encompassing biological responses to drugs. For instance, the transcriptome data of cultured cells and toxicopathological images of mice treated with a compound represent the effects of the compound in vitro and in vivo, respectively.
View Article and Find Full Text PDFRef-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitor.
Angiogenesis
January 2025
Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
Reduction-oxidation factor-1 or apurinic/apyrimidinic endonuclease 1 (Ref-1/APE1) is a crucial redox-sensitive activator of transcription factors such as NF-κB, HIF-1α, STAT-3 and others. It could contribute to key features of ocular neovascularization including inflammation and angiogenesis; these underlie diseases like neovascular age-related macular degeneration (nAMD). We previously revealed a role for Ref-1 in the growth of ocular endothelial cells and in choroidal neovascularization (CNV).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!